Protective Effect of Curcumin on Acute Airway Inflammation of Allergic Asthma in Mice Through Notch1–GATA3 Signaling Pathway by Lei Chong et al.
Protective Effect of Curcumin on Acute Airway Inflammation
of Allergic Asthma in Mice Through Notch1–GATA3 Signaling
Pathway
Lei Chong,1 Weixi Zhang,1 Ying Nie,2 Gang Yu,1 Liu Liu,1 Li Lin,1 Shunhang Wen,1 Lili Zhu,1
and Changchong Li1,3
Abstract—Curcumin, a natural product derived from the plant Curcuma longa, has been found to have
anti-inflammatory, antineoplastic and antifibrosis effects. It has been reported that curcumin attenuates
allergic airway inflammation in mice through inhibiting NF-κB and its downstream transcription factor
GATA3. It also has been proved the antineoplastic effect of curcumin through down-regulating Notch1
receptor and its downstream nuclear transcription factor NF-κB levels. In this study, we aimed to
investigate the anti-inflammatory effect of curcumin on acute allergic asthma and its underlying
mechanisms. 36 male BALB/c mice were randomly divided into four groups (normal, asthma,
asthma+budesonide and asthma+curcumin groups). BALF (bronchoalveolar lavage fluid) and lung
tissues were analyzed for airway inflammation and the expression of Notch1, Notch2, Notch3,
Notch4 and the downstream transcription factor GATA3. Our findings showed that the levels of
Notch1 and Notch2 receptors were up-regulated in asthma group, accompanied by the increased
expression of GATA3. But the expression of Notch2 receptor was lower than Notch1 receptor.
Curcumin pretreatment improved the airway inflammatory cells infiltration and reversed the increasing
levels of Notch1/2 receptors and GATA3. Notch3 receptor was not expressed in all of the four groups.
Notch4 receptor protein and mRNA expression level in the four groups had no significant differences.
The results of the present study suggested that Notch1 and Notch2 receptor, major Notch1 receptor, p-
layed an important role in the development of allergic airway inflammation and the inhibition of Not-
ch1–GATA3 signaling pathway by curcumin can prevent the development and deterioration of the all-
ergic airway inflammation. This may be a possible therapeutic option of allergic asthma.
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INTRODUCTION
Turmeric is a perennial plant cultivated throughout
the tropics, especially in India, China, and Indonesia. It is
used in a number of culinary preparations and curcumin
gives the curry its unique flavor and color. Curcumin,
isolated from the rhizomes of turmeric, is the main active
component and has been found to have many biological
effects such as anti-inflammation, anti-oxidization, free
radical removal, and anti-cancer [1–3].
Asthma is an airway inflammatory disease, charac-
terized by lung eosinophilia, lymphocytes and neutro-
phils infiltration, mucus hypersecretion and airway hyper-
responsiveness (AHR) to inhaled allergens [4]. Many in-
flammatory cells such as T lymphocytes, eosinophils and
mast cells play a defensive role in the pathogenesis of
asthma, in which the most important element is the activa-
tion of CD4+T cells. CD4+T cells can be divided into Th1
and Th2 types. Th2 reactions result in allergic responses,
such as asthma [5].
Notch signaling pathway is an evolutionarily conserved
cell-to-cell communication cascade that was originally
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identified as a pleiotropic mediator of cell fate in flies. It
plays a critical role in maintaining the balance between cell
proliferation, differentiation, and apoptosis [6]. Guo and
colleges [7] have found that the level of Notch1 was signif-
icantly higher in asthmamice andNotch1 signal may play an
important role in the pathogenesis of asthma by its involve-
ment in Th1/Th2 differentiation.
A previous study demonstrated that curcumin
might attenuate allergic airway inflammation and
hyperresponsiveness in mice through inhibiting NF-κB
[8] and its downstream transcription factor GATA3 [9].
Another research found that the down-regulation of
Notch signaling and its downstream NF-κB by curcumin
may be a novel strategy for the treatment of patients with
pancreatic cancer [10]. These results indicated that
curcumin might have a beneficial effect on asthma through
inhibition of the Notch–GATA3 signaling pathway. Our
aim in the present study was to examine the effect of
curcumin in ovalbumin (OVA)-induced airway inflamma-
tion in a mouse model of asthma.
MATERIALS AND METHODS
Acute Asthma Model Set-up
A total of 36 specific pathogen-free male BALB/c
mice, 4 to 6 weeks old and weighing 18–22 g and obtained
from Shanghai Slac Laboratory Animal Center (Shanghai,
China) were used in this study. All animals were kept in the
animal center of Wenzhou Medical University and accli-
mated for at least a week before the experiments. All care
and treatments of the experimental animals were in strict
accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Insti-
tutes of Health. The Committee on the Ethics of Animal
Experiments of the WenzhouMedical University approved
the protocol (Permit Number: wydw 2009-0002).
The mice were randomly divided into four groups
(normal, asthma, asthma+budesonide and asthma+curcumin
groups). On days 1 and 15, experimental groups of mice
were sensitized by i.p. injection of suspension containing
10 μg OVA (Sigma, USA) and 20 mg Al (OH)3 gel. From
days 25 to 32, they were challenged in an inclosed environ-
ment filled with OVA aerosol (1 mg/ml) for 30 min every
day. The curcumin treatment group received curcumin
(Sigma, USA) fluid (200 mg/kg) from mouth before OVA
challenge until the last challenge and the budesonide group
used budesonide aerosol (0.5 mg/ml). The control group
received normal saline on the same schedule.
Bronchoalveolar Lavage and Lung Tissues Handling
All mice were narcotized by chloral hydrate
(400 mg/kg) and sacrificed within 24 h after the last
challenge. After sacrifice, mice were ligated one side of
the bronchus and bronchoalveolar lavage fluid (BALF)
was collected by flushing one side of the lungs with
three separate normal saline through the trachea. The
rate of recovery was more than 80 %. Different cell
counts were determined for each BALF sample using a
cytometer to be 1×104 cells/ml. The nonlavaged side
of lungs were stored in the Ultra-low temperature
freezer or fixed in 10 % formalin and then made into
5-μm-thick paraffin-embedded tissue sections.
Histology
Lung paraffin sections were stained with hematoxylin
and eosin (HE). The degrees of allergic airway inflamma-
tion were scored by another person who was blinded for
treatment of mice and were assessed according to the
following histologic grading system (scored 0–4): absence
of peribronchial inflammatory cells; a few scattered
peribronchial inflammatory cells involving less than 25 %
of the circumference of the bronchus; focal peribronchial
inflammatory cell infiltrate not completely surrounding a
bronchus (i.e., involving approximately 25–75 % of the
circumference of the bronchus); one definite layer of
peribronchial inflammatory cells completely surrounding
a bronchus; two or more layers of peribronchial inflam-
matory cells completely surrounding a bronchus. In each
lung section, the mean peribronchial inflammatory score
was calculated by adding the scores of all the individual
bronchioles in the lung section and dividing this score by
the number of bronchioles present in the lung section [11].
Immunohistochemistry
Immunohistochemistry was carried out using SP two-
step IHC detection reagent (ZSGB-Bio, China). The pri-
mary antibodies were goat polyclonal anti-Notch1 (1:150;
Santa Cruz Biotechnology, USA), rabbit polyclonal anti-
Notch2 (1:400; Millipore Corporation, USA), goat poly-
clonal anti-Notch3 (1:50; Santa Cruz Biotechnology, USA)
and rabbit polyclonal anti-Notch4 (1:100; Santa Cruz Bio-
technology, USA). All sections were stained with DAB for
a short time and counterstained with hematoxylin. Slices
were examined and imaged with Olympus microscope
(Olympus CX21FS1, Japan) with an attached digital cam-
era using the same system settings for all samples. The
brown colors in the slices were positive areas. The mean
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optical density (MOD) was then detected by Image-Pro
Plus in all slices.
RT-PCR
Total RNA was extracted using Trizol Reagent
(Invitrogen Corporation, USA) according to the
manufacturer's instruction. Two micrograms of RNA was
reverse-transcribed to cDNA by incubating with reverse
transcription reagents (Fermentas Corporation, USA) at
37 °C for 1 h. Primers specific for mouse Notch1, Notch2,
Notch3, Notch4 and β-actin were as follows: for Notch1
the forward primer was TGGAGGTAGGTGCGAAGTG
and the reverse primer was GGCAGCGACAGATGTAT
GAAG, for Notch2 the forward primer was CAACTG
TGAGGTGGACAAAAATG and the reverse primer was
TGTTCATACACGGCTTGGAGATA, for Notch3 the for-
ward primer was TTCTCCTGTCGTTGTCTCCG and the
reverse primer was GGCACTCATCTATGTCACTTTGG,
for Notch4 the forward primer was CACCAGGCTTGGA
AGGGAG and the reverse primer was GAAACCAGG
ACGGCAGAGG, for β-actin the forward primer was
CGGGACCTGACAGACTACCTCAT and the reverse
primer was CCACAGGATTCCATACCCAAGA.
The amplification protocol consisted of preheating at
94 °C×5 min, followed by 32 cycles of denaturation at
94 °C×30 s, annealing×30 s and extension at 72 °C×30 s.
The PCR products were determined by agarose gel elec-
trophoresis and analyzed by SMART Gel image analysis
system.
Western Blotting
The lung tissues were homogenized, incubated in
lysis buffer, added with a protease inhibitor cocktail and
then ultrasonic broken nucleus to obtain extracts of lung
proteins. The samples were loaded to 10 % SDS-PAGE
gels and transferred onto a PVDF membrane (Pierce Com-
pany, USA), then blocked with 5 % skim milk for 2 h. The
blots were probed with the appropriate antibodies to assess
the protein level of NICD1 (Epitomics, USA) and GATA3
(Santa Cruz Biotechnology, USA). The appropriate sec-
ondary antibody, conjugated to peroxidase and the en-
hanced chemiluminescence blotting system, was used for
detection. The loading control was beta-actin.
Statistical Analyses
All results were expressed asmeans ± SD and analyzed
by one-way ANOVA, with SPSS 17.0. A P value <0.05 was
considered statistically significant.
RESULTS
Effect of Curcumin on Acute Airway Inflammation
in BALF
To evaluate the acute airway inflammation of OVA
induced allergic asthma model, the total cell and different
kinds of cell numbers in BALF were determined. Upon
OVA sensitization and challenge, asthma group (A) mice
show increased total cell influx in BALF compared to
normal group (N) (P<0.01). While in curcumin treatment
group (A+Cur) and budesonide group (A+Bud) total cell
influx were significantly decreased compared to asthma
group (P<0.01) but still higher than normal group (P<
0.01) (Fig. 1a). The trend of different kinds of cell numbers
like lymphocyte (Lym), eosinophil (Eos) and neutrophil
(Neu) were similar with the total cells (Fig. 1b).
Effect of Curcumin on Airway Inflammatory Cells
Infiltration in Lung Tissue
HE-stained slides of lung tissue were scored for de-
grees of allergic airway inflammation in a semiquantitative
fashion as described in “Materials and Methods” (Fig. 2a).
OVA challenge resulted in airway inflammation in asthma
group. After curcumin or budesonide treatment, the scores
of airway inflammation were declined compared to asthma
group (P<0.01), corroborating the findings in BALF
shown in Fig. 1 (Fig. 2b).
Effect of Curcumin on Four Notch Receptors
To determine the role of curcumin in Notch receptors,
all of the four Notch receptors protein and mRNA were
detected.
Notch1 and Notch2 receptors
As shown in Fig. 3, the expressions of Notch1 recep-
tor protein and mRNA were both significantly increased
(P<0.01) in asthma group compared with normal
group. After treating with curcumin and budesonide, the
levels of Notch1 receptor and Notch2 receptor proteins and
mRNAwere significantly decreased (P<0.01) (Fig. 4). But
the expression of Notch2 receptor was lower than Notch1
receptor (P<0.01) (Fig. 5).
Notch3 Receptor
Mice in all four groups did not express Notch3 recep-
tor, protein, or mRNA (Fig. 6).
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Notch4 Receptor
The levels of Notch4 receptor protein and mRNA
were very high. However, as shown in Fig. 7, there was
no significant difference between each other among the
four groups.
Effect of Curcumin on Notch1 Signaling Pathway
Since curcumin showed inhibited effect on Notch1
receptor, we than detected the expression of NICD1, the
active fragment of Notch1 receptor, and its downstream
transcription factor GATA3 to determine whether Notch1
Fig. 2. Curcumin attenuated acute airway inflammation in asthmatic mice. aRepresentative HE-stained (light microscopy, ×400) lung tissue slides of normal
group, asthma group, budesonide treatment group and curcumin treatment group. b Semiquantitative pathology scores (described inMaterials andMethods).
Data are means ± SD of eight mice per group. *P<0.01 compared with the normal group; #P<0.01 compared with the asthma group.
Fig. 1. Curcumin inhibited inflammatory cells infiltration in BALF (N normal group,A asthma group, A+Bud budesonide treatment group, A+Cur curcumin
treatment group). a Total cell counts in BALF. b Different cell counts (eosinophils, lymphocytes and neutrophils) in BALF. Data are means ± SD of eight
mice per group. *P<0.01 compared with the normal group; #P<0.01 compared with the asthma group.
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signaling pathway was associated with the inhibited effect
of curcumin. From Fig. 8, we could find that the expres-
sions of NICD1 and GATA3 protein were significantly
increased in asthma group (P<0.01) compared with nor-
mal group, but significantly decreased when treated with
curcumin and budesonide (P<0.01).
DISCUSSION
Curcumin, a hydrophobic polyphenol derived from
the rhizomes of turmeric, has been confirmed to have
numerous therapeutic effects by modern scientific research
[3]. Anti-inflammatory effect is one of the most important
biological effects of curcumin [3, 12]. Some studies demon-
strated that curcumin might attenuate allergic airway inflam-
mation through NF-κB inhibition [8] and might be a novel
therapy for pancreatic cancer through down-regulating the
expression of Notch1 and its downstream transcription fac-
tor NF-κB [10]. So, could allergic airway inflammation of
asthma be attenuated by curcumin through the inhibition of
Notch signaling pathway?
Asthma is a disease of the airways characterized by
chronic inflammation associated with AHR and airway
wall remodeling. Airway inflammation is central to disease
pathophysiology. The airway dysfunction may partly due
to the release of potent inflammatory mediators and partly
due to the remodeling of the airway wall [13, 14]. A large
number of inflammatory cells such as T lymphocytes,
eosinophils and mast cells and inflammatory mediators
such as IL-4, IL-5, IL-9, IL-13, TSLP, CXCL10, CCL11
and RANTES infiltrated into lung tissues, gathered around
the tracheal bronchus, and fluxed into the BALF [5, 15].
Our study found that in OVA-induced allergic asthma mice
model, the numbers of total cells influx in BALF and the
scores of airway inflammation were increased significantly
compared with normal groups. The increasing of total cells
was caused by the increasing of Eos, Lym and Neu, which
was in accordance with the previous studies [16, 17].
All these results suggested that our asthma model was
established successfully. And as expected, we also found
that curcumin pretreatment significantly decreased the
inflammatory cells infiltration in the lung tissues and
BALF, which confirmed the anti-inflammatory effect of
curcumin in allergic asthma.
Fig. 3. Curcumin decreased the expression of Notch1 receptor protein and mRNA. aNotch1 protein expression using immunohistochemistry staining (light
microscopy, ×400). b Notch1 mRNA expression using RT-PCR. c The quantitative data of the protein and mRNA expression of Notch1 receptor. *P<0.01
compared with the normal group; #P<0.01 compared with the asthma group.
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Notch, a kind of transmembrane protein which was
first found in flies, was ideally suited to precisely regulate
cell–cell communication during development of complex
tissues like the lung [18–20]. Recently, it has become
increasingly clear that the Notch signaling plays impor-
tant roles in the immune system such as asthma [6, 20,
21]. One potential role for Notch signaling in the immune
system is promoting peripheral T cells activation, prolif-
eration and cytokine production. There are four Notch
receptors in mammals (Notch1–4), which are bound by
five ligands (Delta-like1, 3 and 4 and Jagged 1, 2) [22].
Different Notch signaling may direct different Th cells
proliferation. Interactions between DLL1/4 and Notch3
were described to promote a Th1-cell phenotype [23–25].
After exposure to Th2 cell stimuli, Notch1 and Notch2
would combine to ligand Jagged 1/2 to induce Th2 cell
differentiation [26–28]. Since Th2 cells are the most
important inflammatory mediators of allergic asthma
[29], we speculate that Notch1 and Notch2 receptor will
be increased in asthma group. And in the previous study,
by inhibiting Notch signal in spleen CD4+T cells of
allergic asthma mice, we have demonstrated in vitro that
Notch signal plays an important role in asthma [30]. In
this study, we demonstrated in vivo that Notch1 and
Notch2 were indeed playing a positive role in asthma,
but the effect of Notch2 was much lower than Notch1.
Notch3 and Notch4 had no effect on asthma. We also
found that in curcumin pretreatment groups, the levels of
Notch1 and Notch2 receptors were significantly
decreased compared to asthma groups though still
higher than normal mice, which suggested that
curcumin might attenuate allergic airway inflammation
through inhibiting Notch signaling.
As described above, when exposure to a Th2 cell
stimuli, Notch1 and Notch2 would be active and release
intracellular domain NICD1 and NICD2 which would
translocate to the nucleus and bind to transcription factor
CSL on the promoter of Gata3 that ultimately leading to
Fig. 4. Curcumin decreased the expression of Notch2 receptor protein and mRNA. aNotch2 protein expression using immunohistochemistry staining (light
microscopy, ×400). b Notch2 mRNA expression using RT-PCR. c The quantitative data of the protein and mRNA expression of Notch2 receptor. *P<0.01
compared with the normal group; #P<0.01 compared with the asthma group.
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the production of Th2 cell cytokines IL4, IL5 and IL13
[6]. Other research studies also confirmed that GATA3
was necessary for Notch induced Th2 differentiation and
identified an upstream Gata3 promoter CSL as a direct
target for Notch signaling [31–33]. Besides, the results
that NF-κB played a critical role in Gata3 expression and
Th2 differentiation in allergic airway inflammation [9]
suggested that NF-κB was one of the upstream factors
of GATA3 which could regulate Th2 differentiation. Then
we considered whether Notch–GATA3 signaling pathway
Fig. 6. Notch3 receptor was not expressed in the four groups. aNotch3 protein expression using immunohistochemistry staining (light microscopy, ×400). b
Notch3 mRNA expression using RT-PCR. c The quantitative data of the protein and mRNA expression of Notch3 receptor.
Fig. 5. The expression of Notch2 receptor was lower than Notch1 receptor. a The quantitative data of the protein expression of Notch1 and Notch2 receptor.
b The quantitative data of the mRNA expression of Notch1 and Notch2 receptor. *P<0.01 compared with Notch2 receptor.
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was an important pathway in allergic asthma and whether
it could be inhibited by curcumin. Since the expression of
Notch2 receptor was much lower than Notch1 receptor,
so we detected Notch1 intracellular domain NICD1 pro-
tein and its downstream transcription factor GATA3 pro-
tein expression in the four groups to explore whether
Fig. 8. Curcumin inhibited the expression of NICD1 and its downstream transcription factor GATA3 protein. a The immunoblot analysis of NICD, GATA-3
andβ-actin. b The quantitative data of the protein expression of NICD1 and GATA3. *P<0.01 compared with the normal group; #P<0.01 compared with the
asthma group.
Fig. 7. Curcumin did not affect the expression of Notch4 receptor. a Notch4 protein expression using immunohistochemistry staining (light mic-
roscopy, ×400). b Notch4 mRNA expression using RT-PCR. c The quantitative data of the protein and mRNA expression of Notch4 receptor.
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curcumin could impair the airway inflammation by
inhibiting Notch1–GATA3 signaling pathway. And we
found that in asthma groups, the expressions of NICD1
and GATA3 proteins were significantly increased than
normal groups. In contrast, pretreating with curcumin
reversed the increasing levels of NICD1 and GATA3.
On the whole, our study proved the anti-inflammatory
effect of curcumin on OVA-induced allergic asthma model
by inhibiting Notch1–GATA3 signaling pathway. There-
fore, curcumin may be considered as a potential agent for
preventing asthma in the future. But before clinical appli-
cation, there is still a long way to run and further and
comprehensive studies are needed.
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